Gilead Sciences
GILD
GILD
1,593 hedge funds and large institutions have $62B invested in Gilead Sciences in 2022 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 737 increasing their positions, 532 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,593
Holders Change
-1
Holders Change %
-0.06%
% of All Funds
27.55%
Holding in Top 10
43
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+34.38%
% of All Funds
0.74%
New
114
Increased
737
Reduced
532
Closed
90
Calls
$1.17B
Puts
$764M
Net Calls
+$410M
Net Calls Change
+$49.2M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$302M |
| 2 |
Amundi
Paris,
France
|
+$137M |
| 3 |
Bank of New York Mellon
New York
|
+$123M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$114M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$110M |
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$224M |
| 2 |
Renaissance Technologies
New York
|
-$209M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$172M |
| 4 |
Morgan Stanley
New York
|
-$149M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$130M |
